Donald Engelman

Donald Max Engelman
Born 1941
Alma mater Reed College, Yale University
Employer Yale University, Stryker Corporation
Awards Guggenheim Fellowship

Scientific career

Thesis Solubilization and Aggregatino Properties of Membrane Components from Mycoplasma Laidlawii (1968)
Doctoral students Mark A. Lemmon[1][2]
Website
medicine.yale.edu/lab/engelman/

Donald Max Engelman (born 1941) is Higgins Professor of Biochemistry at Yale University. He is a member of the National Academy of Sciences (1997), fellow of the American Academy of Arts and Sciences,[3] a fellow of the National Institutes of Health, and has been a Guggenheim fellow.[4] He is a director of the Stryker Corporation.[5] He is involved in the creation of new cancer drugs and treatments.[6] For example, Engelman is involved in research to use peptides to aid in destroying tumors.[7]

Administration, Advising, and Consulting

Engelman has served as Director of Biological Sciences at Yale, an advisor to the Brookhaven National Laboratory, and a consultant to the Los Alamos National Laboratory.[8] He also served as Acting Dean of Yale College in 1991.[9]

Education

Engelman is a graduate (and trustee[10]) of Reed College and Yale University.[11]

Engelman Lab

Engelman directs the Engelman Laboratory at Yale.[12]

Patents

Engelman holds six United States patents for his discoveries.[13]

References

  1. ↑ Lemmon, Mark A.; Flanagan, John M.; Treutlein, Herbert R.; Zhang, Jian; Engelman, Donald M. (1992). "Sequence specificity in the dimerization of transmembrane .alpha.-helixes". Biochemistry. 31 (51): 12719–12725. doi:10.1021/bi00166a002. PMID 1463743.
  2. ↑ Lemmon, Mark Andrew (1993). Specific interactions between transmembrane alpha-helices: Their role in the oligomerization of integral membrane proteins (PhD thesis). Yale University. (subscription required)
  3. ↑ "REED COLLEGE AMERICAN ACADEMY OF ARTS AND SCIENCES AWARDS".
  4. ↑ "All Fellows - John Simon Guggenheim Memorial Foundation". Gf.org. Retrieved 2011-07-06.
  5. ↑ "Donald M. Engelman Profile - Forbes.com". People.forbes.com. Retrieved 2011-07-06.
  6. ↑ redOrbit. "URI Research Couple's Method Targets Cancerous Tumors - Redorbit". Redorbit.
  7. ↑ http://www.healthimaging.com/index.php?option=com_articles&article=19339
  8. ↑ "Reed Magazine: News of the College".
  9. ↑ "A Yale College Dean Is Named". The New York Times. 1991-10-15.
  10. ↑ "List of Public Companies Worldwide, Letter - Businessweek - Businessweek". Businessweek.com.
  11. ↑ "The Engelman Lab - Donald M. Engelman". Yale.edu. Retrieved 2011-07-06.
  12. ↑ "The Engelman Lab". Yale.edu. Retrieved 2011-07-06.
  13. ↑ "Donald M Engelman, Page 1".
This article is issued from Wikipedia - version of the 5/20/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.